PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt Diag Hld Regulatory News (IDHC)

Share Price Information for Int Diag Hld (IDHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.315
Bid: 0.315
Ask: 0.326
Change: 0.0035 (1.10%)
Spread: 0.011 (3.492%)
Open: 0.315
High: 0.315
Low: 0.315
Prev. Close: 0.317
IDHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of radiology business in Egyptian market

14 Aug 2018 09:46

RNS Number : 7448X
Integrated Diagnostics Holdings PLC
14 August 2018
 

IDH launches radiology business in fast-growing Egyptian market

 

A strategic expansion that is set to transform IDH's Egyptian operation into a one-stop-shop diagnostics service provider; the investment is planned to have limited impact on cashflows

 

14 August 2018

 

(Cairo and London) - Integrated Diagnostics Holdings ("IDH," "the Company" or "the Group," IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, is set to launch a radiology business in Egypt.

 

IDH is building a national brand in Egypt with a service offering highly complementary to its existing pathology-focused medical diagnostics services.

 

"Our expansion into a high-value, adjacent segment of our industry is a milestone in the development of IDH on par with the expansion into Africa that now sees operations in three countries outside Egypt contributing double-digit percentages to our top line," said Dr. Hend El Sherbini, Chief Executive Officer of IDH.

 

"Our market in Egypt is growing in the double digits, and so is our top line. Today, more than 75% of customers surveyed by a third-party research provider indicate a preference for consolidated service offerings that feature both pathology and radiology - and there is significant existing demand for us to capture. Our expectation is that our pathology business will deliver new patients to our radiology business and that, in the fullness of time, having both services under one roof will also drive growth in our pathology test volumes."

 

"Importantly, our expansion into the fragmented radiology market will be powered by the strong relationships between our brands and our millions of customers as well as the physicians who trust us to be part of their diagnostic and treatment plans," El Sherbini noted.

 

Al Borg Scan will offer a full range of radiology services, including but not limited to magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, x-ray, mammograms and cath lab facilities. It will draw on Al Borg's brand equity to position itself as a premium service provider offering the full range of imaging services using the latest technology and highly trained staff. Medical equipment suppliers for the new venture are global brand names including Siemens, Hitachi, GE Healthcare, and Fujifilm. The company will emphasize convenience with the rollout of its mobile app and website and reinforce its high-end brand positioning with a premium facility and atmosphere at each of its branches. The business will be led by a group of the nation's most prominent radiologists with a track record at Egypt's leading hospitals and radiology centers.

 

Up to 70% of the cost of the expansion into radiology is now in place through an EGP 130.5 million, eight-year facility from the Ahli United Bank of Egypt. The facility is ring-fenced to Al Borg with no guarantees from, or recourse on, IDH or any of its other subsidiaries. The balance of the investment is planned to be financed from the operating cashflows of Al Borg.

 

IDH delivered 29% top-line growth in the first quarter of 2018, performing 6.6 million tests (+8% compared to 1Q2017) for 1.7 million patients (+13% year-on-year), underscoring the health of its core business as Egypt recovers from a period of devaluation and high inflation. Nigeria is the company's newest expansion market, making its first contribution to the Group's consolidated revenues in 1Q2018. IDH is expected to announce 1H2018 results on 16 August 2018.

 

 

-Ends-

 

 

About Integrated Diagnostics Holdings

 

IDH is the largest fully integrated private-sector medical diagnostics services provider in Egypt, Jordan, Sudan, and Nigeria, comprehensively offering pathology and molecular diagnostics, genetics testing and basic radiology. IDH's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Echo-Scan (Nigeria). IDH is listed on the London Stock Exchange (ticker: IDHC) and was founded in 2012 by the merger of Al Borg and Al Mokhtabar, the most established diagnostics services brands in Egypt.

 

 

Contact

Mr. Sherif El-Ghamrawi

Investor Relations Director

T: +20 (0)2 3345 5530 | M: +20 (0)10 0447 8699 | sherif.elghamrawi@idhcorp.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PRLDMGMRRDZGRZG
Date   Source Headline
9th Aug 20222:50 pmRNSDirector/PDMR Shareholding
5th Aug 20223:27 pmRNSDirector/PDMR Shareholding
4th Aug 20224:09 pmRNSDirector/PDMR Shareholding
3rd Aug 20226:01 pmRNSDirector/PDMR Shareholding
3rd Aug 20224:16 pmRNSDirector/PDMR Shareholding
2nd Aug 202210:43 amRNSDirector/PDMR Shareholding
27th Jul 20229:59 amRNSFinal Dividend Distribution
8th Jun 20228:45 amRNS1st Quarter Results
8th Jun 20227:00 amRNSResult of AGM
1st Jun 20225:39 pmRNSNotice of Results
23rd May 20224:35 pmRNSPrice Monitoring Extension
12th May 20225:37 pmRNSAnnual Financial Report & Notice of AGM
21st Apr 20229:46 amRNSPreliminary Results
31st Mar 202210:04 amRNSIFC and IFC MENA Fund acquire 5% stake in IDH
29th Mar 20228:30 amRNSIDH launches fifth Al-Borg Scan Branch
1st Mar 20222:00 pmRNSDirectorate Change
20th Dec 202110:26 amRNSReplacement: IDH 50% Acquisition of IDC
20th Dec 20218:00 amRNSIDH Acquisition of Islamabad Diagnostic Centre
16th Nov 20217:00 amRNS3rd Quarter Results
12th Nov 202112:03 pmRNSNotice of Results
28th Oct 20214:34 pmRNSNotice of Arbitration
4th Oct 202111:48 amRNSIDH launches third Al-Borg Scan branch
24th Sep 202112:50 pmRNSIDH 1H 2021 Standalone Financial Statements
2nd Sep 20217:00 amRNSHalf-year Report
18th Aug 202110:04 amRNSBiolab to operate testing stations in QAIA
9th Jul 20214:16 pmRNSFinal dividend clarification
30th Jun 202112:21 pmRNSResult of AGM
17th Jun 202110:02 amRNSFinal Dividend Resolution – Date Amendments
7th Jun 20215:24 pmRNSAnnual Financial Report & Notice of AGM
7th Jun 20217:00 amRNSChange of Auditor
2nd Jun 20217:00 amRNS1st Quarter Results
27th May 20215:07 pmRNSShare Transfer Mechanism and Documents
25th May 20217:00 amRNSIDH partners with IFC on USD 45m debt financing
20th May 202111:58 amRNSIDH debuts trading on EGX
19th May 20217:00 amRNSFinal Results
6th May 20216:02 pmRNSFRA dual listing approval
5th May 202110:21 amRNSIDH EGX Dual Listing Approval
22nd Mar 202112:31 pmRNSDual Listing - FRA registration approval
18th Feb 202112:25 pmRNSTrading update for the year ended 31 December 2020
17th Feb 20214:41 pmRNSSecond Price Monitoring Extn
17th Feb 20214:36 pmRNSPrice Monitoring Extension
15th Jan 20214:36 pmRNSPrice Monitoring Extension
31st Dec 202012:40 pmRNSSecond Price Monitoring Extn
31st Dec 202012:35 pmRNSPrice Monitoring Extension
29th Dec 20204:36 pmRNSPrice Monitoring Extension
23rd Dec 20201:35 pmRNSResults of EGM and Subdivision of Share Capital
4th Dec 20207:00 amRNSNotice of Extraordinary General Meeting
27th Nov 20204:36 pmRNSPrice Monitoring Extension
20th Nov 20204:40 pmRNSSecond Price Monitoring Extn
20th Nov 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.